The trial is for mild to moderate psoriasis, NOT j
Post# of 72446
Posted On: 05/25/2016 3:27:41 PM
Re: scottsmith #23004
The trial is for mild to moderate psoriasis, NOT just mild psoriasis. The PR said it met the primary endpoint. So why did you say it failed?
Quote:
And it doesn't mean that it is effective in mild psoriasis, especially when Leo goes out of his way to state that it was more effective in the more severe cases.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
